BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Evangelisti C, Chiarini F, Cappellini A, Paganelli F, Fini M, Santi S, Martelli AM, Neri LM, Evangelisti C. Targeting Wnt/β-catenin and PI3K/Akt/mTOR pathways in T-cell acute lymphoblastic leukemia. J Cell Physiol 2020;235:5413-28. [PMID: 31904116 DOI: 10.1002/jcp.29429] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 13.5] [Reference Citation Analysis]
Number Citing Articles
1 Yu S, Han R, Gan R. The Wnt/β-catenin signalling pathway in Haematological Neoplasms. Biomark Res 2022;10:74. [PMID: 36224652 DOI: 10.1186/s40364-022-00418-9] [Reference Citation Analysis]
2 Chen Y, Zhang Z, Zhang J, Chen X, Guo Y, Li C. RNA sequencing-based identification of microRNAs in the antler cartilage of Gansu red deer ( Cervus elaphus kansuensis ). PeerJ 2022;10:e13947. [DOI: 10.7717/peerj.13947] [Reference Citation Analysis]
3 Toson B, Fortes IS, Roesler R, Andrade SF. Targeting Akt/PKB in pediatric tumors: A review from preclinical to clinical trials. Pharmacol Res 2022;183:106403. [PMID: 35987481 DOI: 10.1016/j.phrs.2022.106403] [Reference Citation Analysis]
4 Temre MK, Yadav S, Goel Y, Pandey SK, Kumar A, Singh SM. Glutor, a Glucose Transporter Inhibitor, Exerts Antineoplastic Action on Tumor Cells of Thymic Origin: Implication of Modulated Metabolism, Survival, Oxidative Stress, Mitochondrial Membrane Potential, pH Homeostasis, and Chemosensitivity. Front Oncol 2022;12:925666. [DOI: 10.3389/fonc.2022.925666] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Jin J, Li F, Fan C, Wu Y, He C. Elevated mir-145-5p is associated with skeletal muscle dysfunction and triggers apoptotic cell death in C2C12 myotubes. J Muscle Res Cell Motil 2022. [PMID: 35753017 DOI: 10.1007/s10974-022-09624-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Zhang L, Zhou S, Zhou T, Li X, Tang J. Targeting the lncRNA DUXAP8/miR-29a/PIK3CA Network Restores Doxorubicin Chemosensitivity via PI3K-AKT-mTOR Signaling and Synergizes With Inotuzumab Ozogamicin in Chemotherapy-Resistant B-Cell Acute Lymphoblastic Leukemia. Front Oncol 2022;12:773601. [PMID: 35311115 DOI: 10.3389/fonc.2022.773601] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Brkic FF, Stoiber S, Maier T, Gurnhofer E, Kenner L, Heiduschka G, Kadletz-wanke L. Targeting Wnt/Beta-Catenin Signaling in HPV-Positive Head and Neck Squamous Cell Carcinoma. Pharmaceuticals 2022;15:378. [DOI: 10.3390/ph15030378] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wang YP, Pan F, Wang YD, Khan A, Liu YP, Yang ML, Cao JX, Zhao TR, Cheng GG. Anti-leukemic effect and molecular mechanism of 11-methoxytabersonine from Melodinus cochinchinensis via network pharmacology, ROS-mediated mitochondrial dysfunction and PI3K/Akt signaling pathway. Bioorg Chem 2022;120:105607. [PMID: 35033818 DOI: 10.1016/j.bioorg.2022.105607] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Lin Z, Lin Z, Zhao Y, Cheng N, Zhang D, Lin J, Zhang H, Lin D. Auranofin and ICG-001 Emerge Synergistic Anti-tumor Effect on Canine Breast Cancer by Inducing Apoptosis via Mitochondrial Pathway. Front Vet Sci 2021;8. [DOI: 10.3389/fvets.2021.772687] [Reference Citation Analysis]
10 Miao X, Liu C, Jiang Y, Wang Y, Kong D, Wu Z, Wang X, Tian R, Yu X, Zhu X, Gong W. BET protein inhibition evidently enhances sensitivity to PI3K/mTOR dual inhibition in intrahepatic cholangiocarcinoma. Cell Death Dis 2021;12:1020. [PMID: 34716294 DOI: 10.1038/s41419-021-04305-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Hiremath IS, Goel A, Warrier S, Kumar AP, Sethi G, Garg M. The multidimensional role of the Wnt/β-catenin signaling pathway in human malignancies. J Cell Physiol 2021. [PMID: 34431086 DOI: 10.1002/jcp.30561] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 19.0] [Reference Citation Analysis]
12 Giacomini E, Minetto S, Li Piani L, Pagliardini L, Somigliana E, Viganò P. Genetics and Inflammation in Endometriosis: Improving Knowledge for Development of New Pharmacological Strategies. Int J Mol Sci 2021;22:9033. [PMID: 34445738 DOI: 10.3390/ijms22169033] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
13 Zhu H, Dong B, Zhang Y, Wang M, Rao J, Cui B, Liu Y, Jiang Q, Wang W, Yang L, Yu A, Li Z, Liu C, Zhang L, Huang X, Zhu X, Wu H. Integrated Genomic Analyses Identify High-Risk Factors and Actionable Targets in T-Cell Acute Lymphoblastic Leukemia.. [DOI: 10.1101/2021.07.17.21260159] [Reference Citation Analysis]
14 Huang Y, Sheng H, Xiao Y, Hu W, Zhang Z, Chen Y, Zhu Z, Wu D, Cao C, Sun J. Wnt/β-catenin inhibitor ICG-001 enhances the antitumor efficacy of radiotherapy by increasing radiation-induced DNA damage and improving tumor immune microenvironment in hepatocellular carcinoma. Radiother Oncol 2021;162:34-44. [PMID: 34214613 DOI: 10.1016/j.radonc.2021.06.034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
15 Huang FL, Yu SJ, Li CL. Role of Autophagy and Apoptosis in Acute Lymphoblastic Leukemia. Cancer Control 2021;28:10732748211019138. [PMID: 34169775 DOI: 10.1177/10732748211019138] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
16 Chen L, Ren M, Cao J, Sang H, Chen H, Xu A, Zhao M. Zuogui Wan alleviated maternal kidney-yin deficiency-induced thymic epithelial cell dysfunction in newborn rats through Wnt/β-catenin signaling pathway. J Ethnopharmacol 2021;279:114337. [PMID: 34146629 DOI: 10.1016/j.jep.2021.114337] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Kobar K, Collett K, Prykhozhij SV, Berman JN. Zebrafish Cancer Predisposition Models. Front Cell Dev Biol 2021;9:660069. [PMID: 33987182 DOI: 10.3389/fcell.2021.660069] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
18 Martelli AM, Evangelisti C, Paganelli F, Chiarini F, McCubrey JA. GSK-3: a multifaceted player in acute leukemias. Leukemia 2021;35:1829-42. [PMID: 33811246 DOI: 10.1038/s41375-021-01243-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
19 Matthijssens F, Sharma ND, Nysus M, Nickl CK, Kang H, Perez DR, Lintermans B, Van Loocke W, Roels J, Peirs S, Demoen L, Pieters T, Reunes L, Lammens T, De Moerloose B, Van Nieuwerburgh F, Deforce DL, Cheung LC, Kotecha RS, Risseeuw MD, Van Calenbergh S, Takarada T, Yoneda Y, van Delft FW, Lock RB, Merkley SD, Chigaev A, Sklar LA, Mullighan CG, Loh ML, Winter SS, Hunger SP, Goossens S, Castillo EF, Ornatowski W, Van Vlierberghe P, Matlawska-Wasowska K. RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemia. J Clin Invest 2021;131:141566. [PMID: 33555272 DOI: 10.1172/JCI141566] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
20 Yu DH, Chen C, Liu XP, Yao J, Li S, Ruan XL. Dysregulation of miR-138-5p/RPS6KA1-AP2M1 Is Associated With Poor Prognosis in AML. Front Cell Dev Biol 2021;9:641629. [PMID: 33732707 DOI: 10.3389/fcell.2021.641629] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
21 Luo Y, Yuan J, Huang J, Yang T, Zhou J, Tang J, Liu M, Chen J, Chen C, Huang W, Zhang H. Role of PRPS2 as a prognostic and therapeutic target in osteosarcoma. J Clin Pathol 2021;74:321-6. [PMID: 33589531 DOI: 10.1136/jclinpath-2020-206505] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Zhang Y, Wang X. Targeting the Wnt/β-catenin signaling pathway in cancer. J Hematol Oncol 2020;13:165. [PMID: 33276800 DOI: 10.1186/s13045-020-00990-3] [Cited by in Crossref: 212] [Cited by in F6Publishing: 236] [Article Influence: 106.0] [Reference Citation Analysis]
23 Ruan Y, Kim HN, Ogana H, Kim YM. Wnt Signaling in Leukemia and Its Bone Marrow Microenvironment. Int J Mol Sci 2020;21:E6247. [PMID: 32872365 DOI: 10.3390/ijms21176247] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
24 Jasek-Gajda E, Jurkowska H, Jasińska M, Lis GJ. Targeting the MAPK/ERK and PI3K/AKT Signaling Pathways Affects NRF2, Trx and GSH Antioxidant Systems in Leukemia Cells. Antioxidants (Basel) 2020;9:E633. [PMID: 32709140 DOI: 10.3390/antiox9070633] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
25 Soares-Lima SC, Pombo-de-Oliveira MS, Carneiro FRG. The multiple ways Wnt signaling contributes to acute leukemia pathogenesis. J Leukoc Biol 2020;108:1081-99. [PMID: 32573851 DOI: 10.1002/JLB.2MR0420-707R] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
26 Chiarini F, Paganelli F, Martelli AM, Evangelisti C. The Role Played by Wnt/β-Catenin Signaling Pathway in Acute Lymphoblastic Leukemia. Int J Mol Sci 2020;21:E1098. [PMID: 32046053 DOI: 10.3390/ijms21031098] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]